secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0001493152-24-050830
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 5.02, 2.01, 3.02, 3.03, 5.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals acquires mushroom patent for 515k shares; CEO Cohen secures 75.5% voting control of subsidiary M&P
--------------------------------------------------------------------------------

- Acquired mushroom patent WO 2023/086647 from Greenfield Investments for 515,000 restricted shares of common stock.
- Contributed substantially all assets (MangoRx Mexico and UK) to new subsidiary Mango & Peaches Corp.
- CEO Jacob Cohen received 1.7M common shares (25.4%) and Series A preferred with 51% voting power, totaling 75.5% voting control of M&P.
- CEO base salary raised to $360k/year; severance increased to 3x salary plus target bonus; term extended to Dec 2027.
- Granted Greenfield a co-exclusive license to patents for 10% royalty on gross sales starting Dec 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224050830/0001493152-24-050830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224050830/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer